214 related articles for article (PubMed ID: 23018647)
1. Mitochondrial-targeted nitroxides disrupt mitochondrial architecture and inhibit expression of peroxiredoxin 3 and FOXM1 in malignant mesothelioma cells.
Cunniff B; Benson K; Stumpff J; Newick K; Held P; Taatjes D; Joseph J; Kalyanaraman B; Heintz NH
J Cell Physiol; 2013 Apr; 228(4):835-45. PubMed ID: 23018647
[TBL] [Abstract][Full Text] [Related]
2. Peroxiredoxin 3 levels regulate a mitochondrial redox setpoint in malignant mesothelioma cells.
Cunniff B; Wozniak AN; Sweeney P; DeCosta K; Heintz NH
Redox Biol; 2014; 3():79-87. PubMed ID: 25462069
[TBL] [Abstract][Full Text] [Related]
3. Peroxiredoxin 3 is a redox-dependent target of thiostrepton in malignant mesothelioma cells.
Newick K; Cunniff B; Preston K; Held P; Arbiser J; Pass H; Mossman B; Shukla A; Heintz N
PLoS One; 2012; 7(6):e39404. PubMed ID: 22761781
[TBL] [Abstract][Full Text] [Related]
4. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
[TBL] [Abstract][Full Text] [Related]
5. Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant Mesothelioma.
Cunniff B; Newick K; Nelson KJ; Wozniak AN; Beuschel S; Leavitt B; Bhave A; Butnor K; Koenig A; Chouchani ET; James AM; Haynes AC; Lowther WT; Murphy MP; Shukla A; Heintz NH
PLoS One; 2015; 10(5):e0127310. PubMed ID: 26011724
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial metabolism in cancer stem cells: a therapeutic target for colon cancer.
Song IS; Jeong YJ; Han J
BMB Rep; 2015 Oct; 48(10):539-40. PubMed ID: 26350748
[TBL] [Abstract][Full Text] [Related]
7. Detoxification of Mitochondrial Oxidants and Apoptotic Signaling Are Facilitated by Thioredoxin-2 and Peroxiredoxin-3 during Hyperoxic Injury.
Forred BJ; Daugaard DR; Titus BK; Wood RR; Floen MJ; Booze ML; Vitiello PF
PLoS One; 2017; 12(1):e0168777. PubMed ID: 28045936
[TBL] [Abstract][Full Text] [Related]
8. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.
Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H
J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371
[TBL] [Abstract][Full Text] [Related]
9. Lipophilic triphenylphosphonium derivatives enhance radiation-induced cell killing via inhibition of mitochondrial energy metabolism in tumor cells.
Yasui H; Yamamoto K; Suzuki M; Sakai Y; Bo T; Nagane M; Nishimura E; Yamamori T; Yamasaki T; Yamada KI; Inanami O
Cancer Lett; 2017 Apr; 390():160-167. PubMed ID: 28093283
[TBL] [Abstract][Full Text] [Related]
10. Hyperoxia Causes Mitochondrial Fragmentation in Pulmonary Endothelial Cells by Increasing Expression of Pro-Fission Proteins.
Ma C; Beyer AM; Durand M; Clough AV; Zhu D; Norwood Toro L; Terashvili M; Ebben JD; Hill RB; Audi SH; Medhora M; Jacobs ER
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):622-635. PubMed ID: 29419407
[TBL] [Abstract][Full Text] [Related]
11. Rapid peroxynitrite reduction by human peroxiredoxin 3: Implications for the fate of oxidants in mitochondria.
De Armas MI; Esteves R; Viera N; Reyes AM; Mastrogiovanni M; Alegria TGP; Netto LES; Tórtora V; Radi R; Trujillo M
Free Radic Biol Med; 2019 Jan; 130():369-378. PubMed ID: 30391677
[TBL] [Abstract][Full Text] [Related]
12. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma.
Uddin S; Hussain AR; Ahmed M; Siddiqui K; Al-Dayel F; Bavi P; Al-Kuraya KS
Haematologica; 2012 Jul; 97(7):1092-100. PubMed ID: 22271891
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Forkhead box protein M1 by thiostrepton increases chemosensitivity to doxorubicin in T-cell acute lymphoblastic leukemia.
Wang JY; Jia XH; Xing HY; Li YJ; Fan WW; Li N; Xie SY
Mol Med Rep; 2015 Jul; 12(1):1457-64. PubMed ID: 25760224
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of FOXM1 by thiostrepton sensitizes medulloblastoma to the effects of chemotherapy.
Lin J; Zheng Y; Chen K; Huang Z; Wu X; Zhang N
Oncol Rep; 2013 Oct; 30(4):1739-44. PubMed ID: 23912794
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial division inhibitor 1 reduces dynamin-related protein 1 and mitochondrial fission activity.
Manczak M; Kandimalla R; Yin X; Reddy PH
Hum Mol Genet; 2019 Jan; 28(2):177-199. PubMed ID: 30239719
[TBL] [Abstract][Full Text] [Related]
17. Expression of Forkhead box M1 in soft tissue leiomyosarcoma: Clinicopathologic and in vitro study using a newly established cell line.
Maekawa A; Kohashi K; Setsu N; Kuda M; Iura K; Ishii T; Matsunobu T; Nakatsura T; Iwamoto Y; Oda Y
Cancer Sci; 2016 Jan; 107(1):95-102. PubMed ID: 26560505
[TBL] [Abstract][Full Text] [Related]
18. Effect of mitochondrially targeted carboxy proxyl nitroxide on Akt-mediated survival in Daudi cells: Significance of a dual mode of action.
Variar G; Pant T; Singh A; Ravichandran A; Swami S; Kalyanaraman B; Dhanasekaran A
PLoS One; 2017; 12(4):e0174546. PubMed ID: 28426671
[TBL] [Abstract][Full Text] [Related]
19. FOXM1 is an oncogenic mediator in Ewing Sarcoma.
Christensen L; Joo J; Lee S; Wai D; Triche TJ; May WA
PLoS One; 2013; 8(1):e54556. PubMed ID: 23365673
[TBL] [Abstract][Full Text] [Related]
20. A high-throughput real-time in vitro assay using mitochondrial targeted roGFP for screening of drugs targeting mitochondria.
Chandrasekharan A; Varadarajan SN; Lekshmi A; Lupitha SS; Darvin P; Chandrasekhar L; Pillai PR; Santhoshkumar TR; Pillai MR
Redox Biol; 2019 Jan; 20():379-389. PubMed ID: 30408753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
